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Abstract
Background To evaluate retinal reperfusion, anastomosis,
and compensation following radial optic neurotomy for
ischemic nonperfused central retinal vein occlusion.
Methods Prospective, non-comparative, interventional case
series of 13 patients with ischemic, nonperfused central
retinal vein occlusion underwent decompression surgery
with a radial optic neurotomy and adjunctive intraocular
triamcinolone. Patients were followed for 1 year after
surgery, and were analyzed in the preoperative and
postoperative stages determining: visual acuity by ETDRS
chart (LogMar) and retinal thickness with optical coher-
ence tomography. Fluorescein angiography was performed
at regular intervals to evaluate the capillary perfusion
grade. Intraocular pressure was measured and fundus was
examined.
Results Visual acuity and retinal thickness improved in
10/13 (77%) patients after surgery at 1-year follow-up.
Adequate retinal reperfusion was achieved in ten of the
13 eyes. Acute reperfusion occurred in six eyes within
2 weeks of surgery and a shunt vessel at the optic disk
developed in four eyes within 4 months. In the remaining
three eyes, retinal reperfusion was not observed by
fluorescein angiography. No complications were noted
in any of the patients.
Conclusion Surgical decompression promoted mechanical
reperfusion of the occluded vessel in 10/13 (77%) cases. In
6/13 patients (46%) reperfusion occurred within 2 weeks of
surgery, and in 4/13 patients (31%) collateral vessels
formed within 4 months.
Keywords Centralretinalveinocclusion.Radialoptic
neurotomy.Anastomosis
Introduction
Among patients with central retinal vein occlusion
(CRVO), 34% develop capillary nonperfusion and retinal
ischemia with at least ten disc areas of nonperfusion [1].
Iris neovascularization and neovascular glaucoma occur in
45 to 85% of eyes affected by ischemic CRVO and in only
5% of initially non-ischemic CRVO [2]. Until recently,
there has been no effective treatment for CRVO confirmed
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DOI 10.1007/s00417-009-1187-2by multicentric studies. Visual function may be seriously
and permanently damaged without appropriate treatment.
The etiology and pathogenesis of CRVO, a multifac-
torial retinal vascular disease [3], are not yet understood
[4], although histopathologic studies suggest that the
lamina cribrosa is the site of thrombus formation.
Histopathologic studies performed on enucleated eyes
due to CRVO between 1974 and 1979 by Green et al.
[5], with a 6-year follow-up, indicated that a thrombus site
in CRVO was at or behind the lamina cribrosa in 24 of 29
eyes, with the thrombus located in front of the lamina
cribrosa in only five eyes. Opremcak et al. [6, 7]r e p o r t e d
the importance of the optic disk anatomy in the lamina
cribrosa area for CRVO. In their opinion, the narrow
passage at which the optic nerve diameter shrinks to
1.5 mm is the area of hemodynamic turbulence that leads
to thrombus formation, and the anatomic alterations that
create an optic nerve bottleneck justify a surgical approach
for treating central vein occlusion.
Medical therapy is often disappointing, as only those
hemodynamic parameters that lead to complications
(increased blood viscosity and hypertension) can be
modified, and it is rarely effective for inducing reperfu-
sion. As reported by the Central Vein Occlusion Study [8, 9],
laser treatment (panretinal, focal, or grid) can stop retinal and
iris neoangiogenesis, but has little effect on improving visual
acuity (VA). The recent use of anti-vascular endothelial
growth factor and anti-inflammatory drugs provide pending
results as of today, because no large-scale prospective trial
has been published.
In the present study, we evaluated the validity of
Opremcak’s technique and examined the mechanisms
involved in retinal perfusion.
Materials and methods
A prospective, non-comparative, interventional case series
was designed to evaluate the outcome of radial optic
neurotomy (RON) in 13 patients with nonperfused central
retinal vein occlusion, defined angiographically as eyes
with ten disc areas or more of retinal capillary nonperfusion
[10]. We have enrolled only patients without large areas of
hemorrhage in the periphery of the retina, but we have
included patients with large hemorrhage around the optic
nerve.
The 13 patients were all older than 60 years of age
(69.8±6.7) with CRVO occurring within the previous
12 months and a preoperative VA of ≤0.1 LogMar, without
neovascularization or neovascular glaucoma and posterior
vitreous already detached before surgery, confirmed by
ophthalmoscopic observation with Goldmann Lens. No
patients had received any previous treatment with anti-
VEGF or corticosteroid drugs before surgery. The reperfusion
of the occluded venous vessel, the decrease in capillary
venous transit time and the decrease of tortuosity, were in our
opinion a successful result.
VA and intraocular pressure were measured in all
patients. Fundus examination (including the retinal
periphery), fluorescein angiography (to establish perfu-
sion state), and optical coherence tomography (OCT3
Stratus) for evaluating foveal depression and retinal
thickness were performed preoperatively and postopera-
tively. Patients were followed for 1 year postoperatively,
and each of these examinations was repeated at 1 week
postoperatively and then monthly. Fluorescein angiography
was performed once a month for the first 2 months, then
every 4 months. In only one of the four patients with
anastomosis we performed an ICG angiography to show
the drainage routes into retinochoroidal collateral circula-
tion. Visual field testing (Humphrey 24-2) was performed
preoperatively and at 8 months after RON in patients with
normal fixation.
All patients provided informed consent, and Ethics
Committee approval was obtained. The study protocol
adhered to the tenets of the Declaration of Helsinki. To
eliminate the effect of variations in technique and data
collection, all surgeries were performed by a single
surgeon. Standard surgical techniques were used to perform
pars plana vitrectomy, as follows. The central vitreous cone
was carefully removed up to the insertion of the optic nerve
to eliminate possible residual vitreoretinal adhesions from
the vascular peduncle emerging from the disk, although
vitreous detachment had already occurred before surgery.
The perfusion pressure was increased to reduce the risk of
bleeding at the moment of incision, which was made using
a CRVO blade (Synergetics, Inc., St. Charles, MO, USA)
designed to safely and accurately cut around the optic
nerve. The sharp edge of the calibrated blade (two-sided
asymmetric blade: sharp/blunted) was directed at the
avascular portion of the nasal-side margin of the optic disk,
and the incision edges were spread to decompress the
vessels by making small rotatory movements on the blade
axis. The nasal side of the optic disk was selected to avoid
the risk of injury to the maculopapillary nerve fibers. The
incision was made radial to the nerve and parallel to the
nerve fiber layer to avoid the major vessels.
When the surgical maneuver was completed, before the
blade was extracted, the perfusion pressure was decreased
to physiologic pressure conditions (18–20 mmHg). In the
case of hemorrhage, the pressure was increased and the
maneuver was repeated until hemorrhage stopped. Then,
the blade was extracted. At the end of the surgery,
triamcinolone acetonide (KENACORT®; 4 mg/0.1 ml)
was injected into the vitreous cavity. Neither intraoperative
laser photocoagulation nor gas tamponade was used in any
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peeled in any of the patients.
Results
The preoperative and postoperative fluorescein angiography
and OCT results are shown in Figs. 1, 2,a n d3.
Demographic data are reported in Table 1 with measured
data of visual acuity and retinal thickness of all 13 patients.
To investigate the difference between pre-operative and
post-operative data, a standard t-test was performed using a
significance level of 5%.
In the first place, visual acuity values showed a significant
difference after surgery (p<0.05) (Fig. 4). It is important to
stress that not one of the 13 patients experienced a worsening
in VA, not even those patients (3/13, 23%) where retinal
reperfusion after RON was not achieved. Best-corrected
visual acuity, with an average gain of five Snellen lines, was
observed in 4/13 (31%) patients, where an anastomosis
appeared at the RON incision site. The remaining 6/13
(46%) patients gained at least two Snellen lines.
Secondarily, a statistically significant difference between
pre- and post-operative retinal thickness values was found
(p<0.01) (Fig. 5), showing a decrease of macular edema in
all 13 patients (100%) within 1 month of surgery, probably
due to the anti-edemagenic action of Triamcinolone [11].
In three of the 13 patients (23%), retinal reperfusion
was not observed with fluorescein angiography during
the 1 year of follow-up. In contrast, reperfusion was
achieved in ten of 13 patients (77%) with resolution of
the vessel tortuosity and macular edema, documented by
fluorescein angiography and OCT. In six of these 13
patients (46%), reperfusion occurred immediately, and
was complete within 2 weeks after surgery. Despite
reperfusion after 30 days, three of these six patients
(50%) developed recurrent macula edema, which was
treated with a grid laser and regressed completely after
Fig. 1 Patient 3. a Preoperative
fluorescein angiography showing
marked edema of the optic disc
and venous stasis. b Preoperative
foveal thickness measured by
optical coherence tomography
was 920 µm. Macular edema and
serous detachment of the neuro-
epithelium. Preoperative VA was
0.7 (LogMar). c Postoperative
fluorescein angiography
2m o n t h sa f t e rs u r g e r ys h o w i n g
decreased edema and venous
stasis. d Postoperatively, foveal
thickness decreased to 270 µm,
the macular edema disappeared,
and the serous detachment was
reduced. Postoperative VA was
0.1 (LogMar). e,f Fluorescein
angiography and indocyanine
green angiography 4 months
after surgery showed the anasto-
mosis at the nasal neurotomy site
(arrow)
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incomplete normalization of the retinal foveal thickness
as measured by OCT (approximately 270 µm).
In the remaining four of these 13 patients (31%),
reperfusion did not occur immediately, but occurred later,
with collateral vessel formation that appeared at the RON
incision site in the venous phase of fluorescein angiography
(Figs. 1e, 2e, and 3e) within 4 months after surgery.
Macular edema also recurred in these patients, and a grid
laser treatment was performed in all of them, but OCT
revealed complete recovery of the foveal thickness (about
250 µm) in only one of these patients, and only a partial
decrease in foveal retinal thickness (about 270 µm) in the
other three (Table 1). All ten patients experienced a small
subretinal hemorrhage at the RON site which disappeared
during the 1-year follow-up. No visual field defects
attributable to the RON procedure were observed in any
of the patients.
In the preoperative and postoperative fluorescein
angiography and OCT results, none of the patients
experienced complications such as vitreous hemorrhage,
increased intraocular pressure, endophthalmitis, and
retinal detachment.
Discussion
Without treatment, the natural course of the disease will result
inasignificantvisualhandicap.CRVOisthereforeconsidered
the third most common vascular retinal disease that leads to
blindness [10]. According to the Central Vein Occlusion
Study Group [12], macular edema responds anatomically to
grid photocoagulation, but has no efficacy in the improve-
ment of visual acuity. Panretinal photocoagulation decreases
the neovascular complications of CRVO [13]. Hemodilution
therapy, even for non-ischemic retinal vein occlusion, was
reported in the literature by several studies in which visual
acuity seemed to improve after this therapy [14–16].
In the present study, the patients in whom reperfusion
occurred within 2 weeks after surgery (6/13, 46%) obtained
Fig. 2 Patient 5. a Preoperative
fluorescein angiography showing
macular edema and venous
stasis secondary to central retinal
vein occlusion. b Preoperative
optical coherence tomography
indicates a foveal thickness of
1.100 µm. Preoperative VA was
2.0 (LogMar). c Postoperative
fluorescein angiography showing
resolution of the venous dilation
and tortuosity, and hemorrhage. d
Postoperatively, foveal thickness
decreased to 250 µm with partial
resolution of the edema. Postop-
erative VA was 0.7 (LogMar). e
Fluorescein angiography
4 months after surgery showed
the anastomosis at the nasal RON
site (arrow)
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recovery. These 6/13 (46%) patients gained at least two
Snellen lines. Meanwhile, in 4/13 patients (31%) whose
reperfusion took place after 4 months but with anastomosis,
the final visual result has been even better, with an average
improvement of five Snellen lines. Opremcak shows an
improvement of three or more Snellen lines [17] and
Arumi's outcomes were of one or two Snellen lines but in a
wider series [18]. Thus, compared with the natural course
of CRVO, the effects of RON are beneficial. We obtained a
77% (10/13) reperfusion rate and acute regression of
macular edema in all 13 cases (100%). This is probably
due to the prompt but temporary anti-edemagenic action of
triamcinolone [19–21] and its effect in preserving macular
function until reperfusion occurs; this we observe in CRVO
treated only with intravitreal triamcinolone. However,
macular thickness values in these 3/13 patients without
reperfusion were increased again at a 1-year follow-up, as
shown in Table 1. Vitrectomy alone, without ILM peeling
at the posterior pole, in retinal occlusions, does not seem to
be able to accomplish a complete resolution of edema, with
uncertain results [22, 23].
The recurrence of macular edema appears to be related
to depletion of the effect of triamcinolone; in these cases
we performed grid laser treatment on the posterior pole.
In the current study no significant correlation was found
between VA and occlusion onset timing in the ten
reperfused patients, but the correlation was significant
only in five patients (of these ten) that showed a visual
recovery useful for reading because the blood–retinal
barrier had not yet suffered permanent damage.
None of the patients developed neovascular glaucoma,
probably due to reperfusion and removal of the vitreous gel
that mediates the retinal or iris neovascularization. Thus,
this surgical procedure might limit the extent of retinal
ischemia and its complications.
VA recovery was dependent on the retinal thickness
examined by OCT. Good VA was maintained if retinal
Fig. 3 Patient 6. a Preoperative
fluorescein angiography showing
extensive intraretinal hemor-
rhages and venous turgidity. b
Preoperative foveal thickness
measured by optical coherence
tomography was 750 µm. Pre-
operative VA was 0.7 (LogMar).
c Postoperative fluorescein angi-
ography showing resolution with
normal retinal vasculature. d
Postoperative foveal thickness
was 270 µm. Postoperative VA
was −0.1 (LogMar). e Fundus
photograph 4 months after
surgery showed anastomosis at
the nasal incision site (arrow)
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Therefore, an increase in VA was significantly correlated
with a decrease in macular edema. Further, VA improve-
ment seemed to be correlated with the onset of occlusion
(the more recent the occlusion, the better the VA recovery).
Although three (23%) of the 13 patients did not achieve
reperfusion, ten (77%) of the 13 obtained adequate retinal
reperfusion. In six (46%) of these 13, reperfusion devel-
oped within 2 weeks after surgery, with verified vessel
decompression. In four (31%) of the 13, reperfusion
developed within 4 months, but with collateral vessel
formation, consistent with the report by Arumi et al. [18].
The mechanisms underlying the development of collateral
vessels in these four patients may be related to accelerated
Fig. 5 Scatter plot showing the pre and post-operative values of
retinal thickness (µm)
Fig. 4 Scatter plot of the pre- and post-operative values of Snellen
Visual Acuity (the regression line showed is for illustrative purpose
only)
Table 1 Demographic data of 13 patients with ischemic nonperfused central retinal vein occlusion (CRVO) for 1-year follow-up
Patients (no./sex/ age/eye) Occlusion onset
(days, months)
ETDRS VA(LogMAR) OCT (μm) Laser Anastomosis Formation
(Yes–No)
Pre Post Pre Post (Yes–No)
1/F/61/R 23 days 2.0 1.0 1.120 350 Yes No
2/F/71/L 20 days 0.4 −0.3 350 270 Yes Yes
3/M/74/R 4 months 0.7 −0.1 920 270 Yes Yes
4/M/74/R 2 months 0.4 0.3 400 270 No No
5/M/78/R 8 months 2.0 0.7 1.100 250 Yes Yes
6/F/75/R 4 months 0.7 −0.1 750 270 Yes Yes
7/M/76/L 4 months 1.0 0.2 960 340 Yes No
8/F/63/L 8 months 1.0 1.0 1.000 1,000 No No
9/F/71/R 8 months 1.0 0.7 900 270 No No
10/F/62/L 4 months 1.0 1.0 980 970 No No
11/F/68/L 1 month 0.4 −0.2 390 270 No No
12/F/76/L 4 months 0.7 0.0 850 310 Yes No
13/M/58/R 2 months 0.7 0.7 830 800 No No
M = Male
F = Female
R = Right eye
L = Left eye
VA = Visual acuity (LogMAR units) with ETDRS chart
OCT = Optical coherence tomography (foveal thickness)
172 Graefes Arch Clin Exp Ophthalmol (2010) 248:167–173development of the retinochoroidal collateral routes induced
byRON.Infact,accordingtoTakahashi[24], the natural time
course of CRVO ranges from 1.0 to 9.3 years (mean
3.6 years), and papillary vascular loops appeared to connect
the retinal veins and choroidal veins in ten of the 13 eyes.
Recovery of VA and prognosis in patients with new
collateral formation were better than that in patients who
did not develop any vascular formations. The fluorescein
angiography results indicated that normalization of retinal
thickness improved postoperative functional recovery
(Table 1).
We think that the retinal reperfusion and the improve-
ment of VA in our patients were caused by the release of
central vein compression through the cut at the cribriform
plate and the scleral outlet, which increased the venous
outflow and retinal circulation, and by the development of
a new anastomosis, which allowed the blood to drain. In
fact, the presence of collateral circulation suggested that
capillary draining occurred at the macular level.
These results suggest that RON is a low-risk alternative
therapy, but a randomized study with a larger number of
patients is necessary to establish the factors important for
developing collateral circulation that allows for blood
drainage beyond the occluded vessel.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
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provided the original author(s) and source are credited.
References
1. The Eye Disease Case-Control Study Group (1996) Risk
factors for central retinal vein occlusion. Arch Ophthalmol
114:545–554
2. Rath EZ, Frank RN, Shin DH, Kim C (1992) Risk factors for
retinal vein occlusions: a case-controlled study. Ophthalmology
99:509–514
3. Hayreh SS (1994) Retinal vein occlusion. Indian J Ophthalmol
42:109–132
4. Hayreh SS (2005) Prevalent misconceptions about acute retinal
vascular occlusive disorders. Prog Retin Eye Res 24:493–519
5. Green WR, Chan CC, Hutchins GM, Terry JM (2005) Central
retinal vein occlusion: a prospective histopathologic study of 29
eyes in 28 cases. Retina 25:27–55
6. Opremcak EM, Bruce RA, Lomeo MD et al (2001) Radial optic
neurotomy for central vein occlusion. Retina 21:408–415
7. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE (2006)
Radial optic neurotomy for central retinal vein occlusion. Retina
26:297–305
8. The Central Vein Occlusion Study Group (1997) Natural history
and clinical management of central retinal vein occlusion. Arch
Ophthalmol 115:486–491
9. The Central Vein Occlusion Study Group N report (1995) A
randomized clinical trial of early panretinal photocoagulation
for ischemic central vein occlusion. Ophthalmology 102:1434–
1444
10. The Central Vein Occlusion Study Group (1993) Baseline and
early natural history report: the central vein occlusion study. Arch
Ophthalmol 111:1087–1095
11. Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcin-
olone acetonide as treatment of macular edema in central retinal
vein occlusion. Graefes Arch Clin Exp Ophthalmol 240(9):782–
783
12. The Central Vein Occlusion Study Group M Report (1995)
Evaluation of grid pattern photocoagulation for macular edema
in central vein occlusion. Ophthalmology 102:1425–1433
13. Laatikainen L, Kohner EM, Khoury D, Blach RK (1977) Panretinal
photocoagulation in central retinal vein occlusion: a randomized
controlled clinical study. Br J Ophthalmol 61:741–753
14. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G,
Soubrane G (2001) Effect of isovolemic hemodilution in central
retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 239:909–
914
15. Hansen LL, Wiek J, Wiederholt M (1989) A randomised
prospective study of treatment of non-ischaemic central retinal
vein occlusion by isovolaemic haemodilution. Br J Ophthalmol
73:895–899
16. Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ,
Reim M (1994) Hemodilution therapy in central retinal vein
occlusion. One-year results of a prospective randomized study.
Graefes Arch Clin Exp Ophthalmol 232(1):33–39
17. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE, Borkowski
LM (2006) Radial optic neurotomy with adjunctive intraocular
triamcinolone for central retinal vein occlusion: 63 consecutive
cases. Retina 26:306–313
18. Garcia-Arumi J, Boixedera A, Martinez-Castillo V, Castillo R,
Dou A, Corcostegui B (2003) Chorioretinal anastomosis after
radial optic neurotomy for central retinal vein occlusion. Arch
Ophthalmol 121:1385–1391
19. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E
(2002) Intravitreal triamcinolone acetonide for macular oedema due
to central retinal vein occlusion. Br J Ophthalmol 86:247–248
20. Park CH, Jaffe GJ, Fekrat S (2003) Intravitreal triamcinolone
acetonide in eyes with cystoid macular edema associated with
central retinal vein occlusion. Am J Ophthalmol 136:419–425
21. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA,
Gangnon RE, Puliafito CA (2004) Intravitreal triamcinolone for the
treatment of macular edema associated with central retinal vein
occlusion. Arch Ophthalmol 122:1131–1136
22. DeCroos FC, Shuler RK Jr, Stinnett S, Fekrat S (2009) Pars
plana vitrectomy, internal limiting membrane peeling, and panretinal
endophotocoagulationformacularedemasecondarytocentralretinal
vein occlusion. Am J Ophthalmol 147(4):627–633
23. Mandelcorn MS, Mandelcorn E, Guan K, Adatia FA (2007)
Surgical macular decompression for macular edema in retinal vein
occlusion. Can J Ophthalmol 42(1):116–122
24. Takahashi K, Muraoka K, Kishi S, Shimizu K (1998) Formation
of retinochoroidal collaterals in central retinal vein occlusion. Am
J Ophthalmol 126:91–99
Graefes Arch Clin Exp Ophthalmol (2010) 248:167–173 173